Atexakin alfa

N/A

Report date: 2024/02/05 16:46:17

Base Information

Drug NameAtexakin alfa
Drug Alias Name阿替白介素αatexakina alfa阿特白介素-6αatexakine alfaatexakinum alfa +[10] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-6 receptor alpha subunit agonistsInterleukin-6 receptor subunit beta agonists
TargetsInterleukin-6 receptor alpha subunitInterleukin-6 receptor subunit beta
Therapy Area/IndicationsDiabetic NeuropathiesPeripheral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesWeizmann Institute Of Science
China Registration ClassN/A

Develop Information

Active CompaniesWeizmann Institute Of ScienceNew Life TherapeuticsRelief Therapeutics Holding +[7] 
Inactive CompaniesN/A
Active IndicationsDiabetic NeuropathiesPeripheral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A